ITRM940328A0 - "uso di prodotti contenenti magnesio nella terapia e nella profilassi di malattie neoplastiche e di malattie di tipo autoimmunitario".- - Google Patents

"uso di prodotti contenenti magnesio nella terapia e nella profilassi di malattie neoplastiche e di malattie di tipo autoimmunitario".-

Info

Publication number
ITRM940328A0
ITRM940328A0 ITRM940328A ITRM940328A ITRM940328A0 IT RM940328 A0 ITRM940328 A0 IT RM940328A0 IT RM940328 A ITRM940328 A IT RM940328A IT RM940328 A ITRM940328 A IT RM940328A IT RM940328 A0 ITRM940328 A0 IT RM940328A0
Authority
IT
Italy
Prior art keywords
diseases
prophylaxis
therapy
products containing
containing magnesium
Prior art date
Application number
ITRM940328A
Other languages
English (en)
Inventor
Giampiero Valletta
Original Assignee
Giampiero Valletta
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Giampiero Valletta filed Critical Giampiero Valletta
Publication of ITRM940328A0 publication Critical patent/ITRM940328A0/it
Priority to ITRM940328A priority Critical patent/IT1272994B/it
Priority to CN95193277A priority patent/CN1111414C/zh
Priority to DK95920208T priority patent/DK0760668T3/da
Priority to RU96124484/14A priority patent/RU2163487C2/ru
Priority to US08/737,743 priority patent/US6248368B1/en
Priority to EP95920208A priority patent/EP0760668B1/en
Priority to DE69529213T priority patent/DE69529213T2/de
Priority to PCT/IT1995/000089 priority patent/WO1995031991A2/en
Priority to CA002190847A priority patent/CA2190847C/en
Priority to PT95920208T priority patent/PT760668E/pt
Priority to ES95920208T priority patent/ES2188663T3/es
Priority to SI9530644T priority patent/SI0760668T1/xx
Priority to AU25742/95A priority patent/AU691617B2/en
Priority to KR1019960706651A priority patent/KR100363031B1/ko
Priority to AT95920208T priority patent/ATE229809T1/de
Priority to JP53018295A priority patent/JP3721196B2/ja
Publication of ITRM940328A1 publication Critical patent/ITRM940328A1/it
Application granted granted Critical
Publication of IT1272994B publication Critical patent/IT1272994B/it
Priority to RU2000132310/14A priority patent/RU2000132310A/ru
Priority to US09/852,619 priority patent/US6589564B2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Transplantation (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ITRM940328A 1994-05-25 1994-05-25 Uso di prodotti contenenti magnesio nella terapia e nella profilassi di malattie neoplastiche e di malattie di tipo autoimmunitario.- IT1272994B (it)

Priority Applications (18)

Application Number Priority Date Filing Date Title
ITRM940328A IT1272994B (it) 1994-05-25 1994-05-25 Uso di prodotti contenenti magnesio nella terapia e nella profilassi di malattie neoplastiche e di malattie di tipo autoimmunitario.-
CA002190847A CA2190847C (en) 1994-05-25 1995-05-24 Use of magnesium-based products for the treatment or prophylaxis of neoplastic and autoimmune diseases
ES95920208T ES2188663T3 (es) 1994-05-25 1995-05-24 Uso de productos que contienen magnesio para el tratamiento o profilaxis de enfermedades neoplasicas o autoinmunes.
RU96124484/14A RU2163487C2 (ru) 1994-05-25 1995-05-24 Применение продуктов на основе магния для лечения или профилактики опухолевых и аутоиммунных заболеваний
US08/737,743 US6248368B1 (en) 1994-05-25 1995-05-24 Use of magnesium based products for the treatment or prophylaxis of autoimmune diseases
EP95920208A EP0760668B1 (en) 1994-05-25 1995-05-24 Use of magnesium-based products for the treatment or prophylaxis of neoplastic and autoimmune diseases
DE69529213T DE69529213T2 (de) 1994-05-25 1995-05-24 Verwendung von magnesium enthaltenden verbindungen zur behandlung oder prophylaxe von krebs- und autoimmunkrankheiten
PCT/IT1995/000089 WO1995031991A2 (en) 1994-05-25 1995-05-24 Use of magnesium-based products for the treatment or prophylaxis of neoplastic and autoimmune diseases
CN95193277A CN1111414C (zh) 1994-05-25 1995-05-24 镁盐或镁配合物的制药用途
PT95920208T PT760668E (pt) 1994-05-25 1995-05-24 Utilizacao de produto a base de magnesio para o tratamento ou profilaxia de doencas neoplasicas e auto-imunes
DK95920208T DK0760668T3 (da) 1994-05-25 1995-05-24 Anvendelse af magnesiumbaserede produkter til behandling eller forebyggelse af neoplastiske og autoimmune sygdomme
SI9530644T SI0760668T1 (en) 1994-05-25 1995-05-24 Use of magnesium-based products for the treatment or prophylaxis of neoplastic and autoimmune diseases
AU25742/95A AU691617B2 (en) 1994-05-25 1995-05-24 Use of magnesium-based products for the treatment or prophylaxis of neoplastic and autoimmune diseases
KR1019960706651A KR100363031B1 (ko) 1994-05-25 1995-05-24 신조직형성과자가면역질환의치료또는예방을위한마그네슘-계생성물의용도
AT95920208T ATE229809T1 (de) 1994-05-25 1995-05-24 Verwendung von magnesium enthaltenden verbindungen zur behandlung oder prophylaxe von krebs- und autoimmunkrankheiten
JP53018295A JP3721196B2 (ja) 1994-05-25 1995-05-24 新生物疾患および自己免疫疾患の治療または予防のためのマグネシウムベースの製品の使用
RU2000132310/14A RU2000132310A (ru) 1994-05-25 2000-12-21 Применение продуктов на основе магния для лечения или профилактики опухолевых и аутоиммунных заболеваний
US09/852,619 US6589564B2 (en) 1994-05-25 2001-05-11 Use of magnesium based products for the treatment of neoplastic diseases

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITRM940328A IT1272994B (it) 1994-05-25 1994-05-25 Uso di prodotti contenenti magnesio nella terapia e nella profilassi di malattie neoplastiche e di malattie di tipo autoimmunitario.-

Publications (3)

Publication Number Publication Date
ITRM940328A0 true ITRM940328A0 (it) 1994-05-25
ITRM940328A1 ITRM940328A1 (it) 1995-11-25
IT1272994B IT1272994B (it) 1997-07-01

Family

ID=11402556

Family Applications (1)

Application Number Title Priority Date Filing Date
ITRM940328A IT1272994B (it) 1994-05-25 1994-05-25 Uso di prodotti contenenti magnesio nella terapia e nella profilassi di malattie neoplastiche e di malattie di tipo autoimmunitario.-

Country Status (15)

Country Link
US (2) US6248368B1 (it)
EP (1) EP0760668B1 (it)
JP (1) JP3721196B2 (it)
KR (1) KR100363031B1 (it)
CN (1) CN1111414C (it)
AT (1) ATE229809T1 (it)
AU (1) AU691617B2 (it)
CA (1) CA2190847C (it)
DE (1) DE69529213T2 (it)
DK (1) DK0760668T3 (it)
ES (1) ES2188663T3 (it)
IT (1) IT1272994B (it)
PT (1) PT760668E (it)
RU (2) RU2163487C2 (it)
WO (1) WO1995031991A2 (it)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1076197C (zh) * 1997-08-20 2001-12-19 许跃远 一种治疗乳腺疾病的药
US6639265B2 (en) 2000-01-26 2003-10-28 Semiconductor Energy Laboratory Co., Ltd. Semiconductor device and method of manufacturing the semiconductor device
US6506412B2 (en) * 2000-11-29 2003-01-14 Sciencebased Health Treatment of dry eye syndrome
US7097860B2 (en) * 2001-08-03 2006-08-29 Aaron Moshenyat Method and composition for treatment of inflammatory and inflammation-related disorders
US6537590B1 (en) * 2002-02-19 2003-03-25 Troy J. Lee Solution and the method of making the same for the treatment of osteoarthritis
RU2232560C2 (ru) * 2002-04-05 2004-07-20 Саратовский научно-исследовательский институт травматологии и ортопедии Способ лечения аутоиммунного артрита у животных
US7247328B2 (en) * 2002-05-31 2007-07-24 Zinpro Corporation Chromium (III) alpha amino acid complexes
US7129375B2 (en) * 2002-10-16 2006-10-31 Zinpro Corporation Metal complexes of α amino dicarboxylic acids
RU2237466C1 (ru) * 2003-02-06 2004-10-10 Покатилов Игорь Олегович Способ коррекции избыточного жироотложения проблемных зон
RU2263316C2 (ru) * 2003-04-04 2005-10-27 Военно-медицинский институт Федеральной пограничной службы Российской Федерации при Нижегородской государственной медицинской академии (ВМИ ФПС РФ при НГМА) Способ диагностики дефицита магния при внутренней патологии
EP1522322A1 (en) * 2003-10-10 2005-04-13 Witte, Frank, Dr. Cartilage regeneration
EP1684815B1 (en) * 2003-10-10 2008-12-17 KW2 Implantattechnologie GmbH Cartilage regeneration by generation of chondrons under high concentrations of magnesium
WO2005077405A1 (en) * 2004-02-06 2005-08-25 Cancer Treatment International Compositions and methods for the treatment of cancer by systemic elevation of lactate and consequent depletion of arginine
US20060141054A1 (en) * 2004-10-25 2006-06-29 Thomas Piccariello Metal coordinated compositions
US7799937B2 (en) 2004-10-25 2010-09-21 Synthonics, Inc. Metal coordinated compositions
US8779175B2 (en) * 2004-10-25 2014-07-15 Synthonics, Inc. Coordination complexes, pharmaceutical solutions comprising coordination complexes, and methods of treating patients
FI119101B (fi) * 2006-01-24 2008-07-31 Medgenerics Oy Magnesiumsuoloja sisältävä hoitoaine kasvainten tai vastaavien hoitoon ja magnesiumsulfaatin käyttö
RU2336076C2 (ru) * 2006-06-22 2008-10-20 Закрытое акционерное общество "Биоамид" Пероральное лекарственное средство для восполнения дефицита магния в организме
US8945505B2 (en) * 2007-02-02 2015-02-03 Panaphix, Inc. Use of arsenic compounds for treatment of pain and inflammation
US8815232B2 (en) 2008-08-26 2014-08-26 Kyon Biotech Ag Compositions and methods for treating cancer
KR102075024B1 (ko) * 2018-01-25 2020-02-07 염창환 마그네슘 화합물을 유효성분으로 포함하는 항암보조제
CN108936149A (zh) * 2018-05-21 2018-12-07 胡宪蕴 一种含纳米硒的多元素复合补充剂及应用
CN109674819B (zh) * 2018-12-21 2023-05-05 博雅干细胞科技有限公司 胎盘间充质干细胞制剂及其治疗硬化病的用途

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5244637A (en) * 1975-10-04 1977-04-07 Fuji Photo Optical Co Ltd Exposure information display device
IT1124697B (it) * 1979-10-26 1986-05-14 Simes Derivati di creatinolo o-fosfato ad azione terapeutica,procedimento per la sua preparazione e relativ-e composizioni farmaceutiche
US4975423A (en) * 1984-06-27 1990-12-04 Colgate-Palmolive Company Inhibition of tumor development
JPS6416A (en) * 1986-12-23 1989-01-05 Santen Pharmaceut Co Ltd Remedy for arthritis
SU1537260A1 (ru) * 1987-08-03 1990-01-23 1-Я Городская Клиническая Больница Г.Новосибирска Способ предупреждени развити отека набухани головного мозга при черепно-мозговой травме
US5035888A (en) * 1988-11-09 1991-07-30 Tadataka Hara Therapeutically useful mineral composition
US5977073A (en) * 1991-06-06 1999-11-02 Life Sciences' Technologies, Inc. Nutrient composition for treatment of immune disorders
US5626883A (en) * 1994-04-15 1997-05-06 Metagenics, Inc. Ascorbic acid compositions providing enhanced human immune system activity

Also Published As

Publication number Publication date
CN1149255A (zh) 1997-05-07
CA2190847A1 (en) 1995-11-30
EP0760668A1 (en) 1997-03-12
AU2574295A (en) 1995-12-18
KR100363031B1 (ko) 2003-04-10
IT1272994B (it) 1997-07-01
JP3721196B2 (ja) 2005-11-30
DK0760668T3 (da) 2003-03-31
WO1995031991A2 (en) 1995-11-30
ITRM940328A1 (it) 1995-11-25
ATE229809T1 (de) 2003-01-15
AU691617B2 (en) 1998-05-21
EP0760668B1 (en) 2002-12-18
RU2000132310A (ru) 2003-01-27
CN1111414C (zh) 2003-06-18
US20010041191A1 (en) 2001-11-15
US6589564B2 (en) 2003-07-08
ES2188663T3 (es) 2003-07-01
WO1995031991A3 (en) 1996-02-15
DE69529213T2 (de) 2003-11-13
US6248368B1 (en) 2001-06-19
KR970703155A (ko) 1997-07-03
DE69529213D1 (de) 2003-01-30
PT760668E (pt) 2003-04-30
JPH10500678A (ja) 1998-01-20
CA2190847C (en) 2004-03-16
RU2163487C2 (ru) 2001-02-27

Similar Documents

Publication Publication Date Title
IL113844A (en) N-(alpha-ETHYLBENZYL)-3-HYDROXY-2-PHENYLQUINOLINE-4-CARBOXAMIDE AND ITS USE IN THE PREPARATION OF MEDICAMENTS
EP0469921A3 (en) Deodorant and product in which the deodorant is used
FI962557A7 (fi) PLA2-inhibiittoreiden käyttö Alzheimerin taudin hoidossa
FI962154L (fi) Koostumus terapeuttisten tuotteiden in vivo valmistusta varten
IL122733A0 (en) Pharmaceutical compositions for use in the treatment of allergic asthma
HUP0001111A3 (en) Aryl sulfonamides and analogues thereof and their use in the treatment of neurodegenerative diseases
ZA899176B (en) Use of acetyl d-carnitine in the therapeutic treatment of glaucoma and pharmaceutical compositions useful in such treatment
HUP9601161A2 (en) Use of retinoids in cosmetic compositions or for the manufacture of pharmaceutical compositions
HU9501532D0 (en) Aldonamides and their use as surfactants
IT8468281A1 (it) Proglumide e composizioni farmaceutiche che la contengono per l'impiego nella terapia di affezioni neoplastiche.
GB9419553D0 (en) Polypeptides and their use in the treatment of auto-immune disease
GB2294637B (en) Therapeutic compositions and methods of use
IL110303A0 (en) Use of nabumetone or 6mna in the manufacture of medicaments
IL115224A0 (en) Preparations for use in the treatment of osteoporosis
NO974486D0 (no) Lavdoserte "Ridogrel"-formuleringer samt anvendelse derav ved behandling av tarmbetennelse
ZA958558B (en) Use of inhibitors of cyclooxygenase in the treatment of neurodegenerative diseases
FI932688A7 (fi) Pinta-aktiivisten aineiden käyttö hankaavien pigmenttien käsittelyssä
EP0427427A3 (en) Use of arylalkylamides in the treatment of neurodegenerative diseases
GB9418222D0 (en) Improvements in the propulsion of cycles
GB2279567B (en) Compositions for the treatment of inflammatory proliferative skin disease and their use
IL109356A0 (en) N-substituted-2-azetidinones and their use in the preparation of n-unsubstituted-2-azetidinones
GB9201058D0 (en) Alkanolamides and cosmetic or cleaning compositions comprising the same
GB9200903D0 (en) Alkanolamides and cosmetic or cleaning compositions comprising the same
ES1022014Y (es) "reposapies con zona para masaje"
SI0760668T1 (en) Use of magnesium-based products for the treatment or prophylaxis of neoplastic and autoimmune diseases

Legal Events

Date Code Title Description
0001 Granted